エクソソーム治療薬と診断薬の世界市場に関する洞察、2030年までの予測

当レポートは、エクソソーム治療薬と診断薬 (Exosome Therapeutics and Diagnostics) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

• 調査範囲
• 市場分析：タイプ別
  • 世界のエクソソーム治療薬と診断薬の市場規模成長率：タイプ別: 2019 VS 2023 VS 2030
  • Treatment
  • Diagnosis
• 市場：用途別
  • 世界のエクソソーム治療薬と診断薬の市場シェア：用途別: 2019 VS 2023 VS 2030
  • Cancer
  • Neurological Diseases
  • Others
• 前提条件と制限
• 調査目的
• 対象期間

第2章 世界の市場成長トレンド

• 世界のエクソソーム治療薬と診断薬の市場展望 (2019-2030)
• 世界のエクソソーム治療薬と診断薬の市場成長トレンド：地域別
  • 世界のエクソソーム治療薬と診断薬 市場規模：地域別: 2019 VS 2023 VS 2030
  • エクソソーム治療薬と診断薬の市場規模実績：地域別 (2019-2024)
  • エクソソーム治療薬と診断薬の市場規模予測：地域別 (2025-2030)
• エクソソーム治療薬と診断薬 市場動向
  • エクソソーム治療薬と診断薬 業界動向
  • エクソソーム治療薬と診断薬 市場の促進要因
  • エクソソーム治療薬と診断薬 市場の課題
  • エクソソーム治療薬と診断薬 市場の抑制要因

第3章 競合情勢：主要企業別

• 世界規模の売上高 エクソソーム治療薬と診断薬 ：競合別
  • 世界のエクソソーム治療薬と診断薬の収益：企業別 (2019-2024)
  • 世界のエクソソーム治療薬と診断薬の収益シェア：企業別 (2019-2024)
• 世界のエクソソーム治療薬と診断薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要企業 エクソソーム治療薬と診断薬, 売上高ランキング, 2022 VS 2023 VS 2024
• 世界のエクソソーム治療薬と診断薬 市場集中度
  • 世界のエクソソーム治療薬と診断薬 市場集中度 (CR5 and HHI)
  • 世界の上位10・上位5企業： エクソソーム治療薬と診断薬の収益 2023
• 世界の主要企業 エクソソーム治療薬と診断薬 本社 および提供地域
• 世界の主要企業 エクソソーム治療薬と診断薬, 製品およびアプリケーション
• 世界の主要企業 エクソソーム治療薬と診断薬, 業界参入時期
• M&A, 拡張計画

第4章 エクソソーム治療薬と診断薬 内訳データ：タイプ別

• 世界のエクソソーム治療薬と診断薬の市場規模実績：タイプ別 (2019-2024)
• 世界のエクソソーム治療薬と診断薬の市場規模予測：タイプ別 (2025-2030)

第5章 エクソソーム治療薬と診断薬 内訳データ：用途別

• 世界のエクソソーム治療薬と診断薬の市場規模実績：用途別 (2019-2024)
• 世界のエクソソーム治療薬と診断薬の市場規模予測：用途別 (2025-2030)

第6章 北米

• 北米のエクソソーム治療薬と診断薬 市場規模 (2019-2030)
• 北米のエクソソーム治療薬と診断薬 市場規模：タイプ別
  • 北米のエクソソーム治療薬と診断薬 市場規模：タイプ別 (2019-2024)
  • 北米のエクソソーム治療薬と診断薬 市場規模：タイプ別 (2025-2030)
  • 北米のエクソソーム治療薬と診断薬の市場シェア：タイプ別 (2019-2030)
• 北米のエクソソーム治療薬と診断薬 市場規模：用途別
  • 北米のエクソソーム治療薬と診断薬 市場規模：用途別 (2019-2024)
  • 北米のエクソソーム治療薬と診断薬 市場規模：用途別 (2025-2030)
  • 北米のエクソソーム治療薬と診断薬の市場シェア：用途別 (2019-2030)
• 北米のエクソソーム治療薬と診断薬 市場規模：国別
  • 北米のエクソソーム治療薬と診断薬 市場規模：国別: 2019 VS 2023 VS 2030
  • 北米のエクソソーム治療薬と診断薬 市場規模：国別 (2019-2024)
  • 北米のエクソソーム治療薬と診断薬 市場 シェア 国別 (2025-2030)
  • 米国
  • カナダ

第7章 欧州

• 欧州のエクソソーム治療薬と診断薬 市場規模 (2019-2030)
• 欧州のエクソソーム治療薬と診断薬 市場規模：タイプ別
  • 欧州のエクソソーム治療薬と診断薬 市場規模：タイプ別 (2019-2024)
  • 欧州のエクソソーム治療薬と診断薬 市場規模：タイプ別 (2025-2030)
  • 欧州のエクソソーム治療薬と診断薬の市場シェア：タイプ別 (2019-2030)
• 欧州のエクソソーム治療薬と診断薬 市場規模：用途別
  • 欧州のエクソソーム治療薬と診断薬 市場規模：用途別 (2019-2024)
  • 欧州のエクソソーム治療薬と診断薬 市場規模：用途別 (2025-2030)
  • 欧州のエクソソーム治療薬と診断薬の市場シェア：用途別 (2019-2030)
• 欧州のエクソソーム治療薬と診断薬 市場規模：国別
  • 欧州のエクソソーム治療薬と診断薬 市場規模：国別: 2019 VS 2023 VS 2030
  • 欧州のエクソソーム治療薬と診断薬 市場規模：国別 (2019-2024)
  • 欧州のエクソソーム治療薬と診断薬 市場規模：国別 (2025-2030)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア
  • 北欧

第8章 中国

• 中国のエクソソーム治療薬と診断薬 市場規模 (2019-2030)
• 中国のエクソソーム治療薬と診断薬 市場規模：タイプ別
  • 中国のエクソソーム治療薬と診断薬 市場規模：タイプ別 (2019-2024)
  • 中国のエクソソーム治療薬と診断薬 市場規模：タイプ別 (2025-2030)
  • 中国のエクソソーム治療薬と診断薬の市場シェア：タイプ別 (2019-2030)
• 中国のエクソソーム治療薬と診断薬 市場規模：用途別
  • 中国のエクソソーム治療薬と診断薬 市場規模：用途別 (2019-2024)
  • 中国のエクソソーム治療薬と診断薬 市場規模：用途別 (2025-2030)
  • 中国のエクソソーム治療薬と診断薬の市場シェア：用途別 (2019-2030)

第9章 アジア（中国を除く）

• アジア地域 エクソソーム治療薬と診断薬 市場規模 (2019-2030)
• アジア地域 エクソソーム治療薬と診断薬 市場規模：タイプ別
  • アジア地域 エクソソーム治療薬と診断薬 市場規模：タイプ別 (2019-2024)
  • アジア地域 エクソソーム治療薬と診断薬 市場規模：タイプ別 (2025-2030)
  • アジア地域 エクソソーム治療薬と診断薬の市場シェア：タイプ別 (2019-2030)
• アジア地域 エクソソーム治療薬と診断薬 市場規模：用途別
  • アジア地域 エクソソーム治療薬と診断薬 市場規模：用途別 (2019-2024)
  • アジア地域 エクソソーム治療薬と診断薬 市場規模：用途別 (2025-2030)
  • アジア地域 エクソソーム治療薬と診断薬の市場シェア：用途別 (2019-2030)
• アジア地域 エクソソーム治療薬と診断薬 市場規模：地域別
  • アジア地域 エクソソーム治療薬と診断薬 市場規模：地域別: 2019 VS 2023 VS 2030
  • アジア地域 エクソソーム治療薬と診断薬 市場規模：地域別 (2019-2024)
  • アジア地域 エクソソーム治療薬と診断薬 市場規模：地域別 (2025-2030)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中近東・アフリカ・中南米

• 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模 (2019-2030)
• 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：タイプ別
  • 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：タイプ別 (2019-2024)
  • 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：タイプ別 (2025-2030)
  • 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬の市場シェア：タイプ別 (2019-2030)
• 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：用途別
  • 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：用途別 (2019-2024)
  • 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：用途別 (2025-2030)
  • 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬の市場シェア：用途別 (2019-2030)
• 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：国別
  • 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：国別: 2019 VS 2023 VS 2030
  • 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：国別 (2019-2024)
  • 中近東・アフリカ・中南米 エクソソーム治療薬と診断薬 市場規模：国別 (2025-2030)
  • ブラジル
  • メキシコ
  • トルコ
  • サウジアラビア
  • イスラエル
  • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

• Evox Therapeutics
• Carmine Therapeutics
• Exopharm
• Aruna Bio
• Capricor Therapeutics
• Mantra Bio
• Adipomics
• ReNeuron
• Aegle Therapeutics
• Sarepta Therapeutics
• Codiak Biosciences
• Exosomics
• Innocan Pharma
• Aethlon Medical
• ExoCoBio
• Organicell
• Puretech
• Versatope
• Vesvigen Therapeutics
• Exosome Plus
• Exosome Diagnostics
• ECHO Biaotech

第12章 アナリストによる分析/結論

第13章 付録

List of Tables

Table 1. Global Exosome Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Treatment

Table 3. Key Players of Diagnosis

Table 4. Global Exosome Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Exosome Therapeutics and Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Exosome Therapeutics and Diagnostics Market Share by Region (2019-2024)

Table 8. Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Exosome Therapeutics and Diagnostics Market Share by Region (2025-2030)

Table 10. Exosome Therapeutics and Diagnostics Market Trends

Table 11. Exosome Therapeutics and Diagnostics Market Drivers

Table 12. Exosome Therapeutics and Diagnostics Market Challenges

Table 13. Exosome Therapeutics and Diagnostics Market Restraints

Table 14. Global Exosome Therapeutics and Diagnostics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Exosome Therapeutics and Diagnostics Market Share by Players (2019-2024)

Table 16. Global Top Exosome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics and Diagnostics as of 2023)

Table 17. Global Exosome Therapeutics and Diagnostics Industry Ranking 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Exosome Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Exosome Therapeutics and Diagnostics, Headquarters and Area Served

Table 20. Global Key Players of Exosome Therapeutics and Diagnostics, Product and Application

Table 21. Global Key Players of Exosome Therapeutics and Diagnostics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Type (2019-2024)

Table 25. Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Type (2025-2030)

Table 27. Global Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Application (2019-2024)

Table 29. Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Exosome Therapeutics and Diagnostics Revenue Market Share by Application (2025-2030)

Table 31. North America Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Exosome Therapeutics and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Exosome Therapeutics and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Exosome Therapeutics and Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Exosome Therapeutics and Diagnostics Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030) & (US$ Million)

Table 63. Evox Therapeutics Company Details

Table 64. Evox Therapeutics Business Overview

Table 65. Evox Therapeutics Exosome Therapeutics and Diagnostics Product

Table 66. Evox Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 67. Evox Therapeutics Recent Development

Table 68. Carmine Therapeutics Company Details

Table 69. Carmine Therapeutics Business Overview

Table 70. Carmine Therapeutics Exosome Therapeutics and Diagnostics Product

Table 71. Carmine Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 72. Carmine Therapeutics Recent Development

Table 73. Exopharm Company Details

Table 74. Exopharm Business Overview

Table 75. Exopharm Exosome Therapeutics and Diagnostics Product

Table 76. Exopharm Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 77. Exopharm Recent Development

Table 78. Aruna Bio Company Details

Table 79. Aruna Bio Business Overview

Table 80. Aruna Bio Exosome Therapeutics and Diagnostics Product

Table 81. Aruna Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 82. Aruna Bio Recent Development

Table 83. Capricor Therapeutics Company Details

Table 84. Capricor Therapeutics Business Overview

Table 85. Capricor Therapeutics Exosome Therapeutics and Diagnostics Product

Table 86. Capricor Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 87. Capricor Therapeutics Recent Development

Table 88. Mantra Bio Company Details

Table 89. Mantra Bio Business Overview

Table 90. Mantra Bio Exosome Therapeutics and Diagnostics Product

Table 91. Mantra Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 92. Mantra Bio Recent Development

Table 93. Adipomics Company Details

Table 94. Adipomics Business Overview

Table 95. Adipomics Exosome Therapeutics and Diagnostics Product

Table 96. Adipomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 97. Adipomics Recent Development

Table 98. ReNeuron Company Details

Table 99. ReNeuron Business Overview

Table 100. ReNeuron Exosome Therapeutics and Diagnostics Product

Table 101. ReNeuron Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 102. ReNeuron Recent Development

Table 103. Aegle Therapeutics Company Details

Table 104. Aegle Therapeutics Business Overview

Table 105. Aegle Therapeutics Exosome Therapeutics and Diagnostics Product

Table 106. Aegle Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 107. Aegle Therapeutics Recent Development

Table 108. Sarepta Therapeutics Company Details

Table 109. Sarepta Therapeutics Business Overview

Table 110. Sarepta Therapeutics Exosome Therapeutics and Diagnostics Product

Table 111. Sarepta Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 112. Sarepta Therapeutics Recent Development

Table 113. Codiak Biosciences Company Details

Table 114. Codiak Biosciences Business Overview

Table 115. Codiak Biosciences Exosome Therapeutics and Diagnostics Product

Table 116. Codiak Biosciences Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 117. Codiak Biosciences Recent Development

Table 118. Exosomics Company Details

Table 119. Exosomics Business Overview

Table 120. Exosomics Exosome Therapeutics and Diagnostics Product

Table 121. Exosomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 122. Exosomics Recent Development

Table 123. Innocan Pharma Company Details

Table 124. Innocan Pharma Business Overview

Table 125. Innocan Pharma Exosome Therapeutics and Diagnostics Product

Table 126. Innocan Pharma Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 127. Innocan Pharma Recent Development

Table 128. Aethlon Medical Company Details

Table 129. Aethlon Medical Business Overview

Table 130. Aethlon Medical Exosome Therapeutics and Diagnostics Product

Table 131. Aethlon Medical Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 132. Aethlon Medical Recent Development

Table 133. ExoCoBio Company Details

Table 134. ExoCoBio Business Overview

Table 135. ExoCoBio Exosome Therapeutics and Diagnostics Product

Table 136. ExoCoBio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 137. ExoCoBio Recent Development

Table 138. Organicell Company Details

Table 139. Organicell Business Overview

Table 140. Organicell Exosome Therapeutics and Diagnostics Product

Table 141. Organicell Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 142. Organicell Recent Development

Table 143. Puretech Company Details

Table 144. Puretech Business Overview

Table 145. Puretech Exosome Therapeutics and Diagnostics Product

Table 146. Puretech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 147. Puretech Recent Development

Table 148. Versatope Company Details

Table 149. Versatope Business Overview

Table 150. Versatope Exosome Therapeutics and Diagnostics Product

Table 151. Versatope Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 152. Versatope Recent Development

Table 153. Vesvigen Therapeutics Company Details

Table 154. Vesvigen Therapeutics Business Overview

Table 155. Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Product

Table 156. Vesvigen Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 157. Vesvigen Therapeutics Recent Development

Table 158. Exosome Plus Company Details

Table 159. Exosome Plus Business Overview

Table 160. Exosome Plus Exosome Therapeutics and Diagnostics Product

Table 161. Exosome Plus Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 162. Exosome Plus Recent Development

Table 163. Exosome Diagnostics Company Details

Table 164. Exosome Diagnostics Business Overview

Table 165. Exosome Diagnostics Exosome Therapeutics and Diagnostics Product

Table 166. Exosome Diagnostics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 167. Exosome Diagnostics Recent Development

Table 168. ECHO Biaotech Company Details

Table 169. ECHO Biaotech Business Overview

Table 170. ECHO Biaotech Exosome Therapeutics and Diagnostics Product

Table 171. ECHO Biaotech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024) & (US$ Million)

Table 172. ECHO Biaotech Recent Development

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Exosome Therapeutics and Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Exosome Therapeutics and Diagnostics Market Share by Type: 2023 VS 2030

Figure 3. Treatment Features

Figure 4. Diagnosis Features

Figure 5. Global Exosome Therapeutics and Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Exosome Therapeutics and Diagnostics Market Share by Application: 2023 VS 2030

Figure 7. Cancer Case Studies

Figure 8. Neurological Diseases Case Studies

Figure 9. Others Case Studies

Figure 10. Exosome Therapeutics and Diagnostics Report Years Considered

Figure 11. Global Exosome Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Exosome Therapeutics and Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Exosome Therapeutics and Diagnostics Market Share by Region: 2023 VS 2030

Figure 14. Global Exosome Therapeutics and Diagnostics Market Share by Players in 2023

Figure 15. Global Top Exosome Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics and Diagnostics as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Exosome Therapeutics and Diagnostics Revenue in 2023

Figure 17. North America Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 19. North America Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 20. North America Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 21. United States Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 25. Europe Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 26. Europe Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 27. Germany Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 35. China Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 36. Asia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 38. Asia Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 39. Asia Exosome Therapeutics and Diagnostics Market Share by Region (2019-2030)

Figure 40. Japan Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Share by Country (2019-2030)

Figure 50. Brazil Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Exosome Therapeutics and Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Evox Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 57. Carmine Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 58. Exopharm Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 59. Aruna Bio Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 60. Capricor Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 61. Mantra Bio Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 62. Adipomics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 63. ReNeuron Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 64. Aegle Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 65. Sarepta Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 66. Codiak Biosciences Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 67. Exosomics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 68. Innocan Pharma Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 69. Aethlon Medical Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 70. ExoCoBio Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 71. Organicell Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 72. Puretech Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 73. Versatope Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 74. Vesvigen Therapeutics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 75. Exosome Plus Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 76. Exosome Diagnostics Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 77. ECHO Biaotech Revenue Growth Rate in Exosome Therapeutics and Diagnostics Business (2019-2024)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed

This research report focuses on the Exosome Therapeutics and Diagnostics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Exosome Therapeutics and Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Treatment
  • 1.2.3 Diagnosis
• 1.3 Market by Application
  • 1.3.1 Global Exosome Therapeutics and Diagnostics Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Cancer
  • 1.3.3 Neurological Diseases
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Exosome Therapeutics and Diagnostics Market Perspective (2019-2030)
• 2.2 Global Exosome Therapeutics and Diagnostics Growth Trends by Region
  • 2.2.1 Global Exosome Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Exosome Therapeutics and Diagnostics Historic Market Size by Region (2019-2024)
  • 2.2.3 Exosome Therapeutics and Diagnostics Forecasted Market Size by Region (2025-2030)
• 2.3 Exosome Therapeutics and Diagnostics Market Dynamics
  • 2.3.1 Exosome Therapeutics and Diagnostics Industry Trends
  • 2.3.2 Exosome Therapeutics and Diagnostics Market Drivers
  • 2.3.3 Exosome Therapeutics and Diagnostics Market Challenges
  • 2.3.4 Exosome Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Exosome Therapeutics and Diagnostics by Players
  • 3.1.1 Global Exosome Therapeutics and Diagnostics Revenue by Players (2019-2024)
  • 3.1.2 Global Exosome Therapeutics and Diagnostics Revenue Market Share by Players (2019-2024)
• 3.2 Global Exosome Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Exosome Therapeutics and Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Exosome Therapeutics and Diagnostics Market Concentration Ratio
  • 3.4.1 Global Exosome Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapeutics and Diagnostics Revenue in 2023
• 3.5 Global Key Players of Exosome Therapeutics and Diagnostics Head office and Area Served
• 3.6 Global Key Players of Exosome Therapeutics and Diagnostics, Product and Application
• 3.7 Global Key Players of Exosome Therapeutics and Diagnostics, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Exosome Therapeutics and Diagnostics Breakdown Data by Type

• 4.1 Global Exosome Therapeutics and Diagnostics Historic Market Size by Type (2019-2024)
• 4.2 Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Type (2025-2030)

5 Exosome Therapeutics and Diagnostics Breakdown Data by Application

• 5.1 Global Exosome Therapeutics and Diagnostics Historic Market Size by Application (2019-2024)
• 5.2 Global Exosome Therapeutics and Diagnostics Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Exosome Therapeutics and Diagnostics Market Size (2019-2030)
• 6.2 North America Exosome Therapeutics and Diagnostics Market Size by Type
  • 6.2.1 North America Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
  • 6.2.2 North America Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030)
  • 6.2.3 North America Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)
• 6.3 North America Exosome Therapeutics and Diagnostics Market Size by Application
  • 6.3.1 North America Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
  • 6.3.2 North America Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030)
  • 6.3.3 North America Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)
• 6.4 North America Exosome Therapeutics and Diagnostics Market Size by Country
  • 6.4.1 North America Exosome Therapeutics and Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
  • 6.4.3 North America Exosome Therapeutics and Diagnostics Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Exosome Therapeutics and Diagnostics Market Size (2019-2030)
• 7.2 Europe Exosome Therapeutics and Diagnostics Market Size by Type
  • 7.2.1 Europe Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
  • 7.2.2 Europe Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030)
  • 7.2.3 Europe Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)
• 7.3 Europe Exosome Therapeutics and Diagnostics Market Size by Application
  • 7.3.1 Europe Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
  • 7.3.2 Europe Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030)
  • 7.3.3 Europe Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)
• 7.4 Europe Exosome Therapeutics and Diagnostics Market Size by Country
  • 7.4.1 Europe Exosome Therapeutics and Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
  • 7.4.3 Europe Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Exosome Therapeutics and Diagnostics Market Size (2019-2030)
• 8.2 China Exosome Therapeutics and Diagnostics Market Size by Type
  • 8.2.1 China Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
  • 8.2.2 China Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030)
  • 8.2.3 China Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)
• 8.3 China Exosome Therapeutics and Diagnostics Market Size by Application
  • 8.3.1 China Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
  • 8.3.2 China Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030)
  • 8.3.3 China Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Exosome Therapeutics and Diagnostics Market Size (2019-2030)
• 9.2 Asia Exosome Therapeutics and Diagnostics Market Size by Type
  • 9.2.1 Asia Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
  • 9.2.2 Asia Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030)
  • 9.2.3 Asia Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)
• 9.3 Asia Exosome Therapeutics and Diagnostics Market Size by Application
  • 9.3.1 Asia Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
  • 9.3.2 Asia Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030)
  • 9.3.3 Asia Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)
• 9.4 Asia Exosome Therapeutics and Diagnostics Market Size by Region
  • 9.4.1 Asia Exosome Therapeutics and Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024)
  • 9.4.3 Asia Exosome Therapeutics and Diagnostics Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Exosome Therapeutics and Diagnostics Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Evox Therapeutics
  • 11.1.1 Evox Therapeutics Company Details
  • 11.1.2 Evox Therapeutics Business Overview
  • 11.1.3 Evox Therapeutics Exosome Therapeutics and Diagnostics Introduction
  • 11.1.4 Evox Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.1.5 Evox Therapeutics Recent Development
• 11.2 Carmine Therapeutics
  • 11.2.1 Carmine Therapeutics Company Details
  • 11.2.2 Carmine Therapeutics Business Overview
  • 11.2.3 Carmine Therapeutics Exosome Therapeutics and Diagnostics Introduction
  • 11.2.4 Carmine Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.2.5 Carmine Therapeutics Recent Development
• 11.3 Exopharm
  • 11.3.1 Exopharm Company Details
  • 11.3.2 Exopharm Business Overview
  • 11.3.3 Exopharm Exosome Therapeutics and Diagnostics Introduction
  • 11.3.4 Exopharm Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.3.5 Exopharm Recent Development
• 11.4 Aruna Bio
  • 11.4.1 Aruna Bio Company Details
  • 11.4.2 Aruna Bio Business Overview
  • 11.4.3 Aruna Bio Exosome Therapeutics and Diagnostics Introduction
  • 11.4.4 Aruna Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.4.5 Aruna Bio Recent Development
• 11.5 Capricor Therapeutics
  • 11.5.1 Capricor Therapeutics Company Details
  • 11.5.2 Capricor Therapeutics Business Overview
  • 11.5.3 Capricor Therapeutics Exosome Therapeutics and Diagnostics Introduction
  • 11.5.4 Capricor Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.5.5 Capricor Therapeutics Recent Development
• 11.6 Mantra Bio
  • 11.6.1 Mantra Bio Company Details
  • 11.6.2 Mantra Bio Business Overview
  • 11.6.3 Mantra Bio Exosome Therapeutics and Diagnostics Introduction
  • 11.6.4 Mantra Bio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.6.5 Mantra Bio Recent Development
• 11.7 Adipomics
  • 11.7.1 Adipomics Company Details
  • 11.7.2 Adipomics Business Overview
  • 11.7.3 Adipomics Exosome Therapeutics and Diagnostics Introduction
  • 11.7.4 Adipomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.7.5 Adipomics Recent Development
• 11.8 ReNeuron
  • 11.8.1 ReNeuron Company Details
  • 11.8.2 ReNeuron Business Overview
  • 11.8.3 ReNeuron Exosome Therapeutics and Diagnostics Introduction
  • 11.8.4 ReNeuron Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.8.5 ReNeuron Recent Development
• 11.9 Aegle Therapeutics
  • 11.9.1 Aegle Therapeutics Company Details
  • 11.9.2 Aegle Therapeutics Business Overview
  • 11.9.3 Aegle Therapeutics Exosome Therapeutics and Diagnostics Introduction
  • 11.9.4 Aegle Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.9.5 Aegle Therapeutics Recent Development
• 11.10 Sarepta Therapeutics
  • 11.10.1 Sarepta Therapeutics Company Details
  • 11.10.2 Sarepta Therapeutics Business Overview
  • 11.10.3 Sarepta Therapeutics Exosome Therapeutics and Diagnostics Introduction
  • 11.10.4 Sarepta Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.10.5 Sarepta Therapeutics Recent Development
• 11.11 Codiak Biosciences
  • 11.11.1 Codiak Biosciences Company Details
  • 11.11.2 Codiak Biosciences Business Overview
  • 11.11.3 Codiak Biosciences Exosome Therapeutics and Diagnostics Introduction
  • 11.11.4 Codiak Biosciences Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.11.5 Codiak Biosciences Recent Development
• 11.12 Exosomics
  • 11.12.1 Exosomics Company Details
  • 11.12.2 Exosomics Business Overview
  • 11.12.3 Exosomics Exosome Therapeutics and Diagnostics Introduction
  • 11.12.4 Exosomics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.12.5 Exosomics Recent Development
• 11.13 Innocan Pharma
  • 11.13.1 Innocan Pharma Company Details
  • 11.13.2 Innocan Pharma Business Overview
  • 11.13.3 Innocan Pharma Exosome Therapeutics and Diagnostics Introduction
  • 11.13.4 Innocan Pharma Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.13.5 Innocan Pharma Recent Development
• 11.14 Aethlon Medical
  • 11.14.1 Aethlon Medical Company Details
  • 11.14.2 Aethlon Medical Business Overview
  • 11.14.3 Aethlon Medical Exosome Therapeutics and Diagnostics Introduction
  • 11.14.4 Aethlon Medical Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.14.5 Aethlon Medical Recent Development
• 11.15 ExoCoBio
  • 11.15.1 ExoCoBio Company Details
  • 11.15.2 ExoCoBio Business Overview
  • 11.15.3 ExoCoBio Exosome Therapeutics and Diagnostics Introduction
  • 11.15.4 ExoCoBio Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.15.5 ExoCoBio Recent Development
• 11.16 Organicell
  • 11.16.1 Organicell Company Details
  • 11.16.2 Organicell Business Overview
  • 11.16.3 Organicell Exosome Therapeutics and Diagnostics Introduction
  • 11.16.4 Organicell Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.16.5 Organicell Recent Development
• 11.17 Puretech
  • 11.17.1 Puretech Company Details
  • 11.17.2 Puretech Business Overview
  • 11.17.3 Puretech Exosome Therapeutics and Diagnostics Introduction
  • 11.17.4 Puretech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.17.5 Puretech Recent Development
• 11.18 Versatope
  • 11.18.1 Versatope Company Details
  • 11.18.2 Versatope Business Overview
  • 11.18.3 Versatope Exosome Therapeutics and Diagnostics Introduction
  • 11.18.4 Versatope Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.18.5 Versatope Recent Development
• 11.19 Vesvigen Therapeutics
  • 11.19.1 Vesvigen Therapeutics Company Details
  • 11.19.2 Vesvigen Therapeutics Business Overview
  • 11.19.3 Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Introduction
  • 11.19.4 Vesvigen Therapeutics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.19.5 Vesvigen Therapeutics Recent Development
• 11.20 Exosome Plus
  • 11.20.1 Exosome Plus Company Details
  • 11.20.2 Exosome Plus Business Overview
  • 11.20.3 Exosome Plus Exosome Therapeutics and Diagnostics Introduction
  • 11.20.4 Exosome Plus Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.20.5 Exosome Plus Recent Development
• 11.21 Exosome Diagnostics
  • 11.21.1 Exosome Diagnostics Company Details
  • 11.21.2 Exosome Diagnostics Business Overview
  • 11.21.3 Exosome Diagnostics Exosome Therapeutics and Diagnostics Introduction
  • 11.21.4 Exosome Diagnostics Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.21.5 Exosome Diagnostics Recent Development
• 11.22 ECHO Biaotech
  • 11.22.1 ECHO Biaotech Company Details
  • 11.22.2 ECHO Biaotech Business Overview
  • 11.22.3 ECHO Biaotech Exosome Therapeutics and Diagnostics Introduction
  • 11.22.4 ECHO Biaotech Revenue in Exosome Therapeutics and Diagnostics Business (2019-2024)
  • 11.22.5 ECHO Biaotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer